Is it Time Yet for Adjuvant Immunotherapy for Patients with DNA Mismatch Repair Deficient Gastric Cancer?

Ann Surg Oncol. 2022 Apr;29(4):2141-2143. doi: 10.1245/s10434-021-11141-4. Epub 2022 Jan 27.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Brain Neoplasms
  • Colorectal Neoplasms* / genetics
  • DNA Mismatch Repair
  • Humans
  • Immunotherapy
  • Neoplastic Syndromes, Hereditary
  • Stomach Neoplasms* / genetics
  • Stomach Neoplasms* / therapy

Supplementary concepts

  • Turcot syndrome